Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07083089 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

Study acronym: SAPHIR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 2 of 4 sitesv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to phenotype hearing in patients with early stage of neurodegenerative disorders to explore the prevalence of various hearing disorders in comparison to a control population. Specific focus is made on patients with speech-in-noise intelligibiltiy deficit despite normal tonal audiograms referred to as hidden hearing loss, with potential identification of associated biomarkers.
Trial Details
NCT Number NCT07083089
Lead Sponsor Cilcare SAS
Conditions
(from sponsor)		 Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD), Healthy Participants
Related terms Cognitive Dysfunction, Parkinson Disease
Enrollment 309 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov